Lucentis
Brand Name: Lucentis
Generic Name: Ranibizumab
Active
Registration Number
BR-1072
Dosage Form
Solution For Injection (Intravitreal)
Issuance Date
May 31, 2024
Expiry Date
May 29, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength10 mg/mL
Packaging2mL USP Type I Clear glass vial + CE-Marked medical device (5 µm filter needle) in a box
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineovascular agents
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
RanibizumabActive
Monograph: Ranibizumab